Management of severe psoriasis in a renal transplant recipient with latent tuberculosis using risankizumab

AG, MY and MC have no conflicts of interest. AS has received honoraria from Abbvie. AB has received honoraria from AbbVie, Almirall, Apogee, Galderma, Incyte, Janssen, J&J, Leo Pharma, Lilly, Novartis, Pfizer, Sanofi, UCB MG has been an investigator and/or has received fees/honoraria as an advisory board member and/or speaker and/or for ad hoc consultancy and/or has received education support and/or travel grants from: NIHR studies, Abbvie, Novartis, Johnson&Johnson, Almirall, LEO Pharma, UCB, Pharmaserve- Lilly, Sanofi, Pfizer, Oruka Therapeutics, Incyte, Nektar, AMGEN, Argenx, MSD, Bristol Myers Squibb, Galderma, L'Oreal, Beiersdorf, Skin+Me/Hair+Me